Welcome, how can we help?
Home Chevron
Sitemap Chevron
Quick Quote Chevron
Different types of insurance Chevron
Life insurance companies Chevron
Life insurance or life assurance? Chevron
Who can I buy life insurance from? Chevron
Policy Types
Critical illness cover Chevron
Family income benefit life insurance Chevron
Income protection insurance Chevron
Level term life insurance
Mortgage protection life insurance Chevron
Mortgage payment protection Chevron
Terminal illness cover Chevron
Total permanent disability
Unemployment insurance Chevron
Waiver of premium
Getting Technical
Childrens critical illness cover Chevron
Legal principles of life insurance Chevron
Living outside the uk
Reviewable vs Guaranteed premiums
Who regulates us? Chevron
Will I get a critical illness? Chevron

 

Home / News / 'Alzheimer's research a priority'

'Alzheimer's research a priority'


03 April 2008 17:35:04



The development of new Alzheimer's treatments mean that sufferers may be given longer and more satisfying lives, a health expert has said.

According to the Alzheimer's Society, there will be over a million people with dementia by 2025, a condition which may affect the life insurance policies of sufferers.

Richard Barker, director general of the Association of the British Pharmaceutical Industry (ABPI), said that with many new treatments "in the pipeline", the industry is looking to find new ways that can, if not reverse the disease, "at least slow the whole process down and therefore give people longer, more useful, more satisfying lives".

"Since we're surviving other diseases, we're getting older and more of us will fall prey to Alzheimer's, so we're very focused on trying to get cures for this devastating disease in particular," he added.

His comments follow a survey conducted by the ABPI to identify which illnesses the British public believe should be a priority for national health spending, enabling the ABPI to determine whether treatments in the research and development pipeline match the public and the NHS' agenda.

The research showed that Alzheimer's is the third most cited disease, after cancer and heart disease, with 11 per cent of the public demanding greater national health spending and 12 per cent more research.

Direct Life and Pensions Services Ltd are one of the UK's leading providers of life insurance, term life assurance, mortgage protection, critical illness and life insurance advice onlineADNFCR-980-ID-18536755-ADNFCR
News Archive

August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007